Psychometric validation of the Japanese version of the lymphedema functioning, disability, and health questionnaire for upper limb lymphedema: A multicenter cross-sectional study. - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/42499074
Explore the psychometric validation of the Japanese Lymph-ICF-UL, assessing quality of life in breast cancer-related upper limb lymphedema with strong validity and reliability.
The Japanese Lymph-ICF-UL questionnaire shows acceptable content validity, internal consistency, and test-retest reliability for assessing HRQOL in breast cancer-related upper limb lymphedema.
A case of recurrent breast cancer with severe hepatic dysfunction: Integrating narrative-based medicine and clinical decision-making. - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/42130269
Explore how narrative-based medicine and shared decision-making supported treatment decisions in recurrent breast cancer with severe hepatic dysfunction using eribulin chemotherapy.
Narrative-based medicine and shared decision-making guide treatment for recurrent breast cancer with severe hepatic dysfunction, using eribulin chemotherapy to align with patient values.
Multidisciplinary clinics in cancer-models, metrics, and meaning: a review. - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/42241230
Discover the diverse structures and outcomes of cancer multidisciplinary clinics (MDCs) in the U.S., with variations in quality metrics across different cancer types.
MDCs have shown statistically significant improvements in overall survival in some studies, but findings are heterogeneous. Further investigation is needed.
Unlocking the ferroptotic window: Lipidomic rewiring and metabolic addiction in EMT-driven breast cancer resistance. - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/42401541
Research on ferroptosis targetability through PROTACs suggests a therapeutic approach for overcoming breast cancer resistance by destabilizing p-EMT infrastructure.
Ferroptosis targetability through PROTACs, specifically targeting scaffold super-hubs like AXL and LMTK3, may overcome breast cancer resistance by destabilizing the p-EMT infrastructure.
Association between endocrine therapy and survival outcomes in estrogen receptor-low breast cancer: a systematic review and meta-analysis. - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/42271640
Endocrine therapy linked to better survival in estrogen receptor-low breast cancer from retrospective studies, highlighting need for further research.
Endocrine therapy improves survival in estrogen receptor-low breast cancer based on retrospective studies. Further prospective research is needed.